An auto-injector is a pen similar to a device utilized to deliver a settled dosage of drug to patients as well as anticipated for self-administration. An auto-injector is steadily turning into the best quality standard in the treatment of different signs like rheumatoid, multiple sclerosis, arthritis, anaphylaxis and others. The greater part of the auto-injectors is spring stacked and the process is moderately easy. These are specific instruments which may possibly be utilized to keep away from needle stick damage and diminish needle fear among patients.
Auto-injectors are prudent as they decrease around 95% of major healthcare expenditure, as there is no requirement to go to hospitals and clinics for the administration of the infusion by healthcare experts. Auto-injectors offer cheap home medicine and lessen the time devoured at out-patient and in-patient care units. For patients needing regular dose administration on daily and weekly schedule, the utilization of auto-injectors lessens the normal cost per injection. A decrease in reliance on healthcare experts is boosting the adoption of auto-injectors and is probably going to expand the revenue development of the overall market over the conjecture time frame.
The worldwide market for auto-injectors accounted for approximately US$ 1700 Million by 2016 end. The overall market is projected to record a double digit CAGR of 15.1% over the estimated period and is anticipated to account for around US$ 7,000 Million by the end of the forecast year 2026.
The anaphylaxis segment is likely to record a CAGR of 15% in revenue terms during 2016–2026, to account for over US$ 6000 Million through 2026. The multiple sclerosis segment is considered to be the second largest lucrative segment of the worldwide market for auto-injectors. The segment accounted for about 5.3% value share by 2016 and is estimated to gain over 5.5% value share by the end of 2026.
Auto-Injectors Market Segmentation By Indication – Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others; By Product – Prefilled Auto-Injectors and Fillable Auto-Injectors; By Distribution Channel – Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores
Key Market Players
The key players in the worldwide market for auto-injectors include: Eli Lilly and Company, Dickinson and Company, Becton, Pfizer Inc., Sanofi, Novartis AG, Mylan N.V., Janssen Global Services LLC, Bayer AG, Amgen Inc., Antares Pharma Inc.
Queries regarding these research findings can be addressed to Future Market Insights’ analysts at email@example.com